Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Direct correlation between Th1 and Th17 responses in immunity to Brucella infection.

Rahmanpour M, Keramat F, Jourghasemi S, Rashidi G, Abdolmaleki M, Solgi G, Hajilooi M.

Microbes Infect. 2019 Jun 8. pii: S1286-4579(19)30058-9. doi: 10.1016/j.micinf.2019.05.002. [Epub ahead of print]

PMID:
31185302
2.

Association of interleukin-17 gene polymorphisms and susceptibility to brucellosis in Hamadan, western Iran.

Keramat F, Kazemi S, Saidijam M, Zamani A, Kohan HF, Mamani M, Eini P, Moghimbigi A, Alikhani MY.

Microbiol Immunol. 2019 Mar;63(3-4):139-146. doi: 10.1111/1348-0421.12675. Epub 2019 Apr 15.

PMID:
30851127
3.

Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia.

Keramat F, Ghasemi Basir HR, Abdoli E, Shafiei Aghdam A, Poorolajal J.

Int J Gen Med. 2018 Jun 13;11:217-223. doi: 10.2147/IJGM.S165190. eCollection 2018.

4.

Seroprevalence of Brucellosis in Butchers, Veterinarians and Slaughterhouse Workers in Hamadan, Western Iran.

Mamani M, Majzoobi MM, Keramat F, Varmaghani N, Moghimbeigi A.

J Res Health Sci. 2018 Feb 10;18(1):e00406.

5.

Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii.

Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP.

Eur J Clin Microbiol Infect Dis. 2018 Mar;37(3):443-454. doi: 10.1007/s10096-018-3189-7. Epub 2018 Jan 20.

PMID:
29353377
6.

Seroprevalence of Brucellosis in Human Immunodeficiency Virus Infected Patients in Hamadan, Iran.

Keramat F, Majzobi MM, Poorolajal J, Ghane ZZ, Adabi M.

Osong Public Health Res Perspect. 2017 Aug;8(4):282-288. doi: 10.24171/j.phrp.2017.8.4.09. Epub 2017 Aug 31.

7.

Effect of hydroxychloroquine on treatment and recurrence of acute brucellosis: a single-blind, randomized clinical trial.

Majzoobi MM, Hashemi SH, Mamani M, Keramat F, Poorolajal J, Ghasemi Basir HR.

Int J Antimicrob Agents. 2018 Mar;51(3):365-369. doi: 10.1016/j.ijantimicag.2017.08.009. Epub 2017 Aug 4.

PMID:
28826825
8.

Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates.

Bardbari AM, Arabestani MR, Karami M, Keramat F, Alikhani MY, Bagheri KP.

Microb Pathog. 2017 Jul;108:122-128. doi: 10.1016/j.micpath.2017.04.039. Epub 2017 Apr 27.

PMID:
28457900
9.

Assessment of Health-related Quality of Life among Patients with Tuberculosis in Hamadan, Western Iran.

Mamani M, Majzoobi MM, Ghahfarokhi SM, Esna-Ashari F, Keramat F.

Oman Med J. 2014 Mar;29(2):102-5. doi: 10.5001/omj.2014.25.

10.

Ocular involvement of brucellosis.

Bazzazi N, Yavarikia A, Keramat F.

Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):95-7. doi: 10.4103/0974-9233.106407.

11.

Epidemiologic, clinical and laboratory findings of patients with brucellosis in Hamadan, west of Iran.

Eini P, Keramat F, Hasanzadehhoseinabadi M.

J Res Health Sci. 2012 Dec 13;12(2):105-8.

12.

Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.

Hashemi SH, Gachkar L, Keramat F, Mamani M, Hajilooi M, Janbakhsh A, Majzoobi MM, Mahjub H.

Int J Infect Dis. 2012 Apr;16(4):e247-51. doi: 10.1016/j.ijid.2011.12.003. Epub 2012 Jan 30.

13.

Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.

Mohammad Alizadeh AH, Ranjbar M, Tehrani AS, Keramat F, Mamani M, Rezazadeh M, Aini P, Khalilian A, Majlesi A, Hajilooi M.

J Microbiol Immunol Infect. 2010 Dec;43(6):519-23. doi: 10.1016/S1684-1182(10)60080-1.

14.

A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.

Keramat F, Ranjbar M, Mamani M, Hashemi SH, Zeraati F.

Trop Doct. 2009 Oct;39(4):207-10. doi: 10.1258/td.2009.090030.

PMID:
19762571
15.

Osteoarticular complications of brucellosis in Hamedan, an endemic area in the west of Iran.

Hashemi SH, Keramat F, Ranjbar M, Mamani M, Farzam A, Jamal-Omidi S.

Int J Infect Dis. 2007 Nov;11(6):496-500. Epub 2007 Mar 6.

16.

Association of susceptibility to brucellosis and interleukin-4 promoter polymorphism.

Rezazadeh M, Hajilooi M, Haidari M, Rafiei A, Alavi SA, Keramat F.

Scand J Infect Dis. 2006;38(11-12):1045-9.

PMID:
17148075
17.

Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.

Ranjbar M, Keramat F, Mamani M, Kia AR, Khalilian FO, Hashemi SH, Nojomi M.

Int J Infect Dis. 2007 Mar;11(2):152-6. Epub 2006 Jun 22.

18.

Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers.

Adibi P, Ghassemian R, Alavian SM, Ranjbar M, Mohammadalizadeh AH, Nematizadeh F, Mamani M, Rezazadeh M, Keramat F, Ardalan A, Esmaeili A, Zali MR.

Saudi Med J. 2004 Oct;25(10):1414-8.

PMID:
15494813

Supplemental Content

Loading ...
Support Center